Edimer Pharmaceuticals investigational therapy (ECP-012)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Edimer Pharmaceuticals investigational therapy (ECP-012), covering 2012-06-28 to 2012-06-28. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia (ECP-012)